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Abstract
In the beginning were neither B cells nor T cells nor antibodies, but innate immune defense alone. The primary functional
theme of innate immunity is the distinction between self and non-self, which is maintained by a vast number of cellular and
subcellular components. In this context, the immense importance of the Toll-like receptors (TLRs) is well established. Positive
(Darwinian) selection seems to be acting on the ligand-binding domains of these molecules, suggesting a selection pattern
similar to that previously observed in the MHC proteins. In sharp contrast to TLRs, the biological signiﬁcance of mannan-
binding lectin (MBL) is controversial, and, concerning humans, it has been suggested that low concentration of MBL in serum
represents a selective advantage. In this mini-review, based on a doctoral thesis, evolutionary aspects of TLRs and MBL are
discussed.
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Innate immunity—a prerequisite for survival
The vertebrate immune defense has two arms: the
innate and the adaptive immune systems. These are
ideal partners because of their different recognition
strategies, which have complementary strengths and
weaknesses (1). Through the use of pattern recogni-
tion receptors (PRRs), the innate immune defense is
highly efﬁcient at distinguishing self from non-self,
but has—due to its non-clonal nature and despite
safety measures like complement control proteins
(2) and the activities of sialic acid-speciﬁc lectins
(siglecs) (3) and signaling regulatory protein a
(SIRPa) (4)—the potential to cause signiﬁcant col-
lateral damage to self tissue. The adaptive immune
defense, relying on clonally expressed receptors, is
highly effective in targeting the immune response
against infection while sparing uninfected tissue;
however, the cells of the adaptive immune defense
cannot by themselves reliably determine the origin of
the antigen they are speciﬁc for. By joined forces, the
evolutionary ancient and immediate innate immune
defense and the younger, highly speciﬁc, but tempo-
rally delayed adaptive immune defense maximize the
survival potential of their host (1).
In bony ﬁsh—the most diverse group of vertebrates
(5)—several innate immunity components are more
active and diverse than their mammalian counterparts
(6). Among piscine Toll-like receptors (TLRs), there
are examples of duplicated genes and wider ligand
repertoires compared to the mammalian equivalents
(7). Two mannan-binding lectins (MBLs) have been
detected in rainbow trout, but there are indications
that these may be members of a larger trout MBL
family (8). Certain complement factors are more
diverse in ﬁsh than in mammals (6), and the mole-
cules of the alternative pathway of complement dis-
play ﬁve to ten times higher titers in ﬁsh (9). These
differences between mammalian and piscine innate
immunity may represent a compensatory strategy,
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limited and slow. Also, the adaptive immune defense
generally develops late in marine species, making the
innate immune defense their only protection against
pathogens during the ﬁrst two or three months
after hatching. The lower anti-pathogen activity of
the innate immune defense in mammals can be
interpreted as an evolutionary shift in function, in
which communication with the adaptive immune
defense and maintenance of homeostasis is becoming
increasingly important (6).
The innate immune defense has previously been
considered unsophisticated and non-speciﬁc, a ‘little
sister’ of the more important adaptive immune
defense. However, the growing awareness of the
immense importance of TLRs has promoted innate
immunity research and led to new insights concerning
its elaborate nature and speciﬁcity, stressing its role as
the primary defense system in all species, including
those which possess an adaptive immune defense. In
mammals, TLRs and MBL occupy central positions
at the border between innate and adaptive immunity:
complement, initiated by MBL, co-ordinates adaptive
immune functions (10), and dendritic cells, the most
specialized antigen-presenting cells, are known to
express TLRs (11). This mini-review, based on a
doctoral thesis, aims to describe evolutionary aspects
of TLRs and MBL and contribute to the discussion
on how natural selection is shaping these molecules
for their roles in host defense.
Who’s there? The recognition strategies of the
innate immune defense
The main task of the innate immune defense is
to discriminate between self and non-self. This
is achieved through three strategies of recognition:
recognition of microbial non-self, recognition
of missing self, and recognition of altered self
(Figure 1) (12).
Recognition of microbial non-self is based on
the interaction between PRRs—such as TLRs and
MBL—and micro-organism-associated molecular
patterns (MAMPs). MAMPs are conserved struc-
tures, invariant in a particular class of micro-
organisms, which are not present within the host.
Furthermore, these structures are essential for the
viability/adaptive ﬁtness of the micro-organism and
thus not easily discarded (13). Secreted PRRs, like
MBL, bind to microbial cells and ﬂag them for phago-
cytosis or elimination by the complement system,
while membrane-bound PRRs, like TLRs, activate
signaling pathways that induce antimicrobial effec-
tor mechanisms and inﬂammation (12). Intercellu-
lar as well as intracellular cross-talk between
TLRs and complement is known. Binding of the
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Figure 1. Three recognition strategies used by the innate immune defense. A: Recognition of microbial non-self induces immune response.
B: Natural killer cells interact with target cells through activating and inhibitory receptors. When both types of receptors are engaged, the
inhibitory receptors are dominant and the natural killer cell is not activated. However, if self marker molecules are missing, the natural killer cell
is released from its state of inhibition. C: Expression of markers of altered self ﬂags the cell for destruction.
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their receptors—C5aR and C3aR, respectively—
modulates TLR4, TLR2/6, and TLR9 signaling
(14). Moreover, pentraxin 3 (PTX3), a PRR belong-
ing to the pentraxin family, is produced by a variety of
cells and tissues in response to TLR signaling and
modulates complement activation through inter-
action with C1q and factor H (15). At the intracellular
level, the complement receptor-3 (CR3), an integrin,
can be transactivated by TLR2 via an inside-
out signaling pathway which is distinct from the
myeloid differentiation primary response protein
88 (MyD88)-dependent pro-inﬂammatory signaling
pathway. Conversely, CR3 can initiate TLR2 and
TLR4 by promoting the recruitment of the adapter
molecule MyD88-adapter-like (Mal) (16). Cross-
communication between TLRs and complement
may serve to avoid misinterpretation of signals from
non-dangerous non-self and help in the ﬁne-tuning of
the subsequent immune response to a particular
microbe (17).
The missing self recognition strategy is based on
molecular markers expressed on healthy cells: if
these markers are missing, the cell is targeted for
destruction. The major histocompatibility complex
I (MHCI) proteins, constitutively expressed on all
nucleated cells but often down-regulated as a result
of viral infection, serve as self markers and ligands
for inhibitory receptors which block the lytic acti-
vity of NK cells. Conversely, recognition of altered
self is based on markers expressed only by abnor-
mal or damaged cells, which thus are ﬂagged for
elimination (12).
Toll-like receptors
Discovery
The ﬁrst TLR was cloned and characterized in
1997 by Ruslan Medzhitov and co-workers: under
the hypothesis that the expression of co-stimulatory
molecules and cytokines by antigen-presenting cells
was induced by a non-clonal component of immunity,
human TLR4 was discovered. It was also found that
this molecule could induce activation of the nuclear
factor kB (NFkB) pathway and expression of the co-
stimulatory molecule B7.1, which is necessary for
activation of naive T cells (18). TLRs have previously
been considered solely dedicated to host defense, but
evidence is emerging that these receptors may also be
involved in central nervous system development and
maintenance (19,20). Advances made recently in the
understanding of Toll-like receptor biology in host
defense and disease have been reviewed by Kawai and
Akira (21).
Evolutionary perspectives
TLR4 is the most ancient TLR, dating its origin
before vertebrate life (22). Today’s mammalian
TLR family can be subdivided into two groups, which
are the result of a gene duplication event prior to the
divergence of invertebrates and vertebrates: the
TLR1 family, consisting of TLRs 1, 2, 6, and 10,
and a second group, comprised of all other TLRs.
Orthologs of TLR1, TLR6, and TLR10 seem to be
present exclusively in mammals (23). TLR10 sepa-
rated from the TLR1/6 precursor about 300 million
years ago, roughly at the time of divergence from
birds, while TLR1 and TLR6 appeared approximately
170 million years later (22). Following duplication,
gene conversion events between TLR1 and TLR6,
limiting the divergence between these two genes,
have been suggested (24). In mice and humans,
remnants of a second, disrupted TLR2-like gene is
located in tandem with the functional version of
TLR2. This indicates the occurrence of a gene
duplication after which one of the gene copies has
developed into a pseudogene. Since there are two
TLR2 genes in chicken, the duplication event prob-
ably occurred before the divergence of mammals and
birds (25).
The nematode Caenorhabditis elegans possesses a
single TLR (Figure 2) (26). On the other hand, the
genome of the purple sea urchin encodes 222 TLRs
(27), demonstrating that in the absence of adaptive
immunity a large repertoire of PRRs may provide a
survival advantage in a pathogen-rich environment
(28). The genome of the Florida lancelet is thought
to harbor roughly 50 TLR genes (29), while at least
20 are known in the South African clawed frog (30).
Seventeen different TLRs are known in bony ﬁsh
(7). The orthologs of TLR6 and TLR10 in mammals
are absent, while TLR14—which has been found only
in aquatic animals, suggesting an aquatic pathogen
(31)—and TLRs 18–23 have been identiﬁed (7).
Some piscine TLRs appear to have a different ligand
repertoire and functional role compared to their
mammalian counterparts: piscine TLR3 has been
shown to respond to viral as well as bacterial MAMPs,
while TLR4 may be acting as an inhibitor of the
MyD88-dependent signaling pathway in zebraﬁsh
(7). TLRs also exhibit a different diversity pattern
in ﬁsh compared to mammals: in rainbow trout,
a soluble TLR5—possibly amplifying ﬂagellin-
induced signaling (32)—is present together with the
membrane-bound version, while two TLR4 genes
and two TLR8 genes have been found in zebraﬁsh,
and two splicing isoforms of TLR9 are present in
gilthead seabream and large yellow croaker (7). In
comparison, soluble versions of TLR2 (33) and
92 I.-M. BergmanTLR4 (34), both with negative regulatory function
towards their respective membrane-bound versions,
are known in mammals.
In the chicken genome, ten TLR genes have been
identiﬁed (Figure 2), one of which–ChTLR15—is
speciﬁc for chicken (25). Ten functional TLRs are
known in humans and pigs (35). In mice, TLRs
11–13 have been identiﬁed (36), but mouse TLR10
is non-functional, due to a retroviral insertion (37).
TLR11 is present as a pseudogene in humans (38).
Controlling the double-edged sword
Due to the potent nature of TLR signaling, TLR
activation is a double-edged sword, being essential
for provoking the innate immune response and
enhancing the adaptive immune response, but
simultaneously opening a door for pathogenesis.
Negative regulation of TLR signaling is achieved
at multiple levels through a large number of mole-
cules (21). During acute bacterial infection, soluble
TLRs can function as decoy receptors, preventing
over-activation of the membrane-bound versions.
Once ligand-receptor interaction has occurred, intra-
cellular regulators further control TLR signaling (39).
Furthermore, TLR signaling is also controlled by
membrane-associated regulators, e.g. single immuno-
globulin interleukin-1 receptor-related molecule
(SIGIRR) (39), through miRNAs (40), by degrada-
tion of TLRs and production of anti-inﬂammatory
cytokines as well as through apoptosis (39).
In addition to this, codon usage offers an alterna-
tive, more indirect mechanism for regulation. It has
been shown that in most human TLR genes, the
codon usage pattern deviates from the general one
in humans, dictating a low level of protein expression
(41). We have recently reported a similar difference
between the general codon usage pattern in pigs and
that in TLR1, TLR2, and TLR6 (42), the alternative
codon usage pattern also extending to TLR10
(unpublished data). It is likely that this speciﬁc
TLR codon usage pattern—mirroring the conditions
in humans—results in protein expression at a low
level. Moreover, at least in piscine TLRs, the leucine-
rich repeats (LRRs) may have a role not only in ligand
recognition but also in the limitation of TLR activa-
tion, since a mutant zebraﬁsh TLR3 construct,
lacking LRRs and most of the endosomal domain,
showed 100 times higher reporter gene expression
compared to the wild-type TLR3 construct (43).
South African clawed frog:
20 TLRs
B and T lymphocytes present
Purple sea urchin:
222 TLRs
Complement present
Caenorhabditis elegans
(nematode): 1 TLR
Florida lancelet: 50 TLRs
Chicken: 10 TLRs Pig: 10 TLRs Man: 10 TLRs Mouse: 13 TLRs Fruit fly: 9 TLRs
Origin of life
Figure 2. Schematic and simpliﬁed overview of the development of the immune defense. Numbers of Toll-like receptors vary between species
and tend to decrease during the course of evolution. Proteins belonging to the complement system are present in the purple sea urchin. The
South African clawed frog possesses an adaptive immune defense based on B and T lymphocytes.
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Seen from an evolutionary point of view and based on
the detailed structure of the extracellular domain,
TLRs can be divided into vertebrate-like TLRs
(V-TLRs) and protostome-like TLRs (P-TLRs)
(27). Applying this approach, the Drosophila Toll fam-
ily (Figure 2) includes eight P-TLRs (Toll included)
and one V-TLR (Toll-9) (29). Phylogenetic analysis of
the Toll/interleukin-1 receptor (TIR) domains in the
Drosophila Toll family reveals that these—Toll-9 being
an exception—are more closely related to one another
than to TLRs in mammals. Thus, it is likely that
the two groups of receptors—Toll and the Drosophila
Toll-related receptors except Toll-9 on the one hand,
and mammalian TLRs on the other—have evolved
independently while carrying out different main func-
tions (44). The difference is further emphasized by
the fact that the physical interaction between mam-
malian TLRs and MAMPs (21) occurs in a completely
different manner compared to the binding of the
endogenous ligand Spätzle by Toll (45).
Flagellin-sensitive 2 (FLS2) in Arabidopsis thaliana,
thale cress, is a transmembrane protein involved—like
TLR5—in the recognition of ﬂagellin. FLS2 is
equipped with an extracellular LRR domain, but
the low degree of sequence similarity between
FLS2 and human TLR5 suggests that these proteins
arose independently. Resistance (R) proteins contain-
ing LRR domains fused to TIR domains are present
in plants, and R proteins resembling either CD14, a
co-receptor in the TLR4 receptor complex, or TLRs
are also known (46). In contrast to animal TIRs, plant
TIR domains may interact directly with pathogen
effectors, while a role in signaling for plant TIR
domains remains to be established. However, some
TIR domain-containing R proteins are found in the
nucleus and may have roles as transcription factors.
Again, these differences in the use of the TIR domain
may imply convergent (47) or parallel (28) evolution
rather than conservation from an early ancestor of
both animals and plants.
Mannan-binding lectin
MBL: an initiator of the complement cascade
The role of the complement cascade in the human
immune defense has recently been reviewed by Zipfel
(10). MBL and ﬁcolins initiate the lectin activation
pathway of complement in co-operation with MBL-
associated serine proteases (MASPs) (48). The lectin
pathway is the most recently described of the main
complement activation pathways (49) but possibly the
most ancient: a glucose-speciﬁc lectin which interacts
with MASPs has been puriﬁed from the sea pineapple
(50), and an ortholog of the mammalian MBLs is
present in lamprey (51). Ficolin-3 has been found to
be the most potent of the lectin pathway initiators in
humans, followed by ﬁcolin-2 and MBL (52). MBL is
similar in structure to C1q, a subunit of the classical
pathway C1 complex, and mammalian MBL—but
not MBL in chicken and ﬁsh—is thought to have
the same ability as C1q to stimulate phagocytosis
through the C1qRp receptor. The function of
MBL/MASPs is equivalent to that of the C1 complex:
C4 and C2 are cleaved, and the classical/lectin path-
way C3 and C5 convertases—C4b2a and C4b2aC3b,
respectively—are formed (48). Recently, a novel
MBL/ﬁcolin-associated protein, representing a short
splice variant of the MASP1 gene and denoted
MAP-1, has been detected in humans. This protein
is expressed in myocardial and skeletal muscle
and thought to inhibit the complement system by
preventing the cleavage of C4 (53).
The MBL molecule
MBL belongs to the protein family of collagenous
lectins, which includes multifunctional proteins
with defensive and housekeeping roles (48). The func-
tions of collagenous lectins and TLRs are known to
intersect: MBL has been found to inhibit mouse
macrophage tumor necrosis factor a (TNFa) produc-
tion—which is a consequence of TLR signaling lead-
ing to activator protein 1 (AP-1) activation (54)—by
shielding Blastomyces dermatitidis epitopes (55), while
in-vitro experiments have shown a dampening effect of
surfactant protein A (SP-A) on pulmonary inﬂamma-
tion caused by zymosan, probably through the binding
of SP-A to TLR2 (56). In most mammals, two forms
of MBL—MBL-A and MBL-C—are present. These
are encoded by separate genes, denoted MBL1 and
MBL2. Duplication of the MBL gene probably
occurred after the divergence of birds and mammals,
since only one MBL gene is present in chicken. In
humans and chimpanzee,MBL1 is a pseudogene (48).
The basic subunit of mammalian MBL is a trimer
composed of three identical monomers, each con-
sisting of four distinct domains: a cysteine-rich
N-terminal domain, a collagen-like domain, a neck
region, and a C-terminal carbohydrate recognition
domain. The collagen-like domain is composed of
numerous G-X-Y motifs (X and Y representing any
amino acid), typical of a helix structure. If a glycine in
a G-X-Y motif is replaced by a more bulky amino
acid, the formation of the trimer triple helix is dis-
turbed. This, in turn, impairs the functionality of the
molecule, since this is dependent on oligomerization
of the basic trimers (57). The binding of the
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dependent on MBLs’ steric speciﬁcity and the spatial
organization of the carbohydrate ligands on the path-
ogenic surface; conversely, self tissue is spared by
these requirements (50). In serum, MBL exists in
complex with MASPs 1–3 and small MBL-associated
protein (sMAP), the latter representing a short splice
variant of the MASP2 gene and playing a regulatory
role in the lectin pathway. When MBL binds to a cell
surface displaying a ﬁtting carbohydrate pattern, the
proenzyme forms of MASPs are cleaved and become
proteolytically active (58).
Differences between species
The abundance, forms, and functions of the collag-
enous lectins vary considerably between species. In
humans, one MBL and three ﬁcolins are expressed,
while there are two ﬁcolins and two MBLs in most
other species. Furthermore, in MBL and ﬁcolins, the
recognition domains are aggregated at one pole,
which creates their sertiform (‘bunch of tulips’)
formation. This facilitates multivalent binding to
monosaccharides on microbial surfaces. In contrast,
in the bovine-speciﬁc conglutinin (CG) and collectin-
46 (CL-46), the recognition domains are distributed
at diametric poles, leading to a cruciform which
facilitates agglutination of targets; however, these
cruciform molecules have not been shown to activate
complement. Moreover, unlike other collagenous
lectin trimers, those of bovine-speciﬁc collectin-43
(CL-43) and human collectin liver 1 (CL-L1) do
not assemble into higher-order oligomers. Differences
like these may reﬂect co-evolution with relevant
pathogens (48).
TLRs and MBL: ﬁnding Mr Darwin—and not
ﬁnding him
Toll-like receptors
The weaknesses of some widely used statistical meth-
ods aiming to identify positive (Darwinian) selection
by comparisons of numbers of non-synonymous
and synonymous single nucleotide polymorphisms
(SNPs) have been pointed out by Hughes and
co-workers (59). If a protein is evolving under positive
selection, then a pattern of dN>dS (i.e. the propor-
tionate number of non-synonymous differences, dN,
exceeding the proportionate number of synonymous
differences, dS) is expected, as has been found regard-
ing the peptide-binding region (PBR) of the MHC
molecules. MHC proteins present peptide antigens
to antigen-speciﬁc T cells. Since MHC molecules
encoded by different alleles present different antigens,
the advantage of a heterozygote in terms of increased
peptide-presentation capacity maintains MHC poly-
morphism. Thus, from a biological point of view,
positive selection repeatedly favoring amino acid
changes in the PBR is reasonable. However, this
pattern may not be characteristic for positive selection
in general. The methods based on comparisons of
non-synonymous and synonymous SNPs often fail to
rule out alternative hypotheses, in particular the relax-
ation of purifying selection and the effects of popu-
lation bottle-necks (59). Furthermore, the dN/dS
statistic, originally developed for quantiﬁcation of
selective pressure in divergent species, has also
been scrutinized and challenged. Even though it is
traditionally used to quantify selection pressure
within populations, it has been shown to be inade-
quate when applied in this manner or for closely
related taxa (60,61).
It is known that many pathogens, among them
Yersinia pestis, express lipid A structures which do
not fully stimulate TLR4 (62), demonstrating that
at least some MAMPs do evolve in response to selec-
tive pressure. Moreover, there is accumulating
evidence of a species-speciﬁc component in TLR
function, which, in turn, might reﬂect co-evolution
with relevant micro-organisms (63). Bovine TLR2/
TLR1(63)andchickenTLR2-type2/TLR1-type2(64)
both display broader ligand speciﬁcities than the cor-
responding receptor complexes in most mammals.
TLR2 in ruminants seems to be subject to a lower
degree of selection compared to TLR2 in other mam-
mals (63), and polymorphism in bovine TLR2 is
known to occur mainly between breeds, the genotype
in a particular breed probably reﬂecting the microﬂora
at hand (65). Furthermore, certain wild-derived
inbred strains of mice differ in TLR3 genotype from
classical laboratory strains (66). Our own ﬁndings,
showing that wild boars and domestic pigs display
different polymorphic patterns in the TLR1, TLR2,
TLR6 (42), and TLR10 (unpublished data) genes,
parallel these observations and further emphasize
that different microbial environments are involved
in shaping the differences in genotypes observed
between populations/strains. To summarize, positive
selection acting on the ligand-binding domains of
TLRs appears reasonable from a biological point of
view. Indeed, the pattern observed in an analysis
of 22 mammalian TLR2 sequences parallels that of
MHC: amino acids responsible for the binding of
MAMPs evolve under positive selection, while regions
important for heterodimerization—especially the TIR
domain—are subject to purifying selection (63).
Moreover, a similar pattern has been reported con-
cerning bovine TLR4 (67). Furthermore, biased
distributions of non-synonymous SNPs, compatible
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parts of the genes, have been reported regarding
porcine TLR genes (68,69). Also, in bony ﬁsh, certain
sites in the LRR domains of TLR9 seem to evolve
under positive selection (70).
Barreiro and co-workers (71) reported evidence for
population-speciﬁc events of positive selection on the
TLR10-1-6 gene cluster, strong purifying selection
acting on the intracellular TLRs, and more relaxed
selective constraint on cell surface TLRs in humans.
Taken as a set, human TLRs have evolved under
purifying selection according to this study (71). In
most TLRs, Wlasiuk and co-workers detected posi-
tive selection between humans and chimpanzees, as
opposed to purifying selection within species (72).
Also, a comparison between human and rhesus mon-
key orthologous gene pairs revealed signiﬁcantly
lower dN—and thus greater functional constraint—
on the TIR domain compared to LRRs in TLR4,
TLR5, TLR7, TLR8, and TLR9, but no positive
selection was reported (23). Bovine TLR10 seems
to evolve under strong purifying selection, indicating
an important function for the corresponding receptor.
This is interesting, since TLR10 is the only member
of the TLR family for which no ligand is known. It
remains to be deﬁned what kind of functional con-
straint might be important enough to justify strong
purifying selection (73). In contrast, relaxed selective
constraint, indicating some degree of redundancy,
has been suggested for human TLR10: in the large-
scale screening project undertaken by Barreiro and
co-workers, TLR10 was found to be by far the most
variable of the human TLR genes (71). Due to
markedly different physiologies, the pathogenic load
and the balance between commensals and pathogens
are likely to differ between ruminants and non-
ruminant species. Thus, species-speciﬁc function
and co-evolution with relevant micro-organisms
might explain why bovine and human TLR10 seem
to be subject to different modes of selection. Our own
ﬁndings regarding polymorphic patterns in the TLR1,
TLR2, TLR6 (42), and TLR10 (unpublished data)
genes in pigs point in the direction of purifying
selection: visualizations of the amino acid positions
corresponding to detected non-synonymous SNPs,
using the crystal structure determined for the human
TLR1-TLR2-lipopeptide complex (74) combined
with protein sequence alignments, indicated that
the majority of the variable positions are distinct
from the ligand-binding site and the dimerization
interface.
It has been argued that positive selection detectable
as a pattern of dN>dS, indicating repeated amino acid
changes at a limited set of codons, is likely to be very
rare. Comparisons of dN and dS would not detect
single non-synonymous changes at single codons,
whole or partial gene deletion, or changes in the
patterns of gene expression; however, such punctual
events are known to produce adaptive genotypes and
likely to be more common (59). Moreover, it has been
pointed out that the highly mutable CpG positions are
much more common in replacement sites in codons
than in introns, rendering the fundamental assump-
tion of equal mutation rates in different parts of the
genome unjustiﬁable. Thus, the intensity of purifying
selection on coding sequences may be greater than
previously inferred (75). In agreement with this,
Roach and co-workers found no support for positive
selection in the vertebrate TLR phylogeny through
evaluation of synonymous/non-synonymous substitu-
tion ratios (36). In conclusion, despite their potential
as a parallel to the MHC proteins as far as patterns of
selection are concerned, a conservative approach
regarding the extent to which positive selection is
acting on and has been detected in TLRs still seems
appropriate.
Mannan-binding lectin
In the coding sequence of the human MBL2 gene,
three non-synonymous SNPs, all with decreasing
effects on MBL concentration, have been identiﬁed.
Two of these SNPs implicate the replacement of a
glycine residue in a G-X-Y motif with an aspartic acid
(the B allele) and a glutamic acid (the C allele),
respectively. Furthermore, three promoter poly-
morphisms affecting MBL serum concentrations
are known. Low-producing MBL alleles are present
at varying frequencies in different human populations
(76). MBL deﬁciency has been found to increase
susceptibility to many infectious diseases (77), but
also, in contrast, to increase resistance against leish-
maniasis (78) and tuberculosis (TB) (79). However,
in the case of TB, the existing view has been chal-
lenged. In a recent meta-analysis carried out by
Denholm and co-workers (80), no signiﬁcant associ-
ation was found between MBL2 genotype and pul-
monary TB infection. However, the majority of the
analyses did not report MBL2 haplotypes inclusive of
promoter polymorphisms. MBL serum concentra-
tions were consistently elevated during TB infection,
but this increase was also of a degree consistent
with the acute-phase reaction. If indeed MBL deﬁ-
ciency does not protect against TB, it is challenging to
propose a different disease that may have promoted
the high frequency of low-producing MBL alleles
observed in some human populations (80). It is
believed that during evolution, the human MBL1
gene has been turned off by the same molecular
mechanisms causing the variant MBL2 alleles, i. e.
96 I.-M. Bergmanmainly through mutations affecting the glycines in the
G-X-Y motifs in the collagen-like domain. This is
consistent with the hypothesis that low MBL levels
represent a selective advantage (81). In the coding
sequence of porcine MBL1, a non-synonymous SNP,
implicating the replacement of the glycine in G-X-Y
motif 16 with a cysteine, has been detected. This SNP
is present at different frequencies in various domestic
pig populations (82) and is assumed to affect MBL-A
concentration in serum (83). The existence of this
SNP in porcine MBL1 may be an indication of
an on-going evolutionary process favoring low-
producing MBL alleles, mirroring what might be
the case in humans. However, the hypothesis of
selection for low-producing MBL alleles in human
populations is not undisputed: balancing selection,
implying an advantage for heterozygotes (84), as well
as neutral evolution and redundancy (85) has been
suggested. The study by Verdu and co-workers (85) is
based on a large-scale sequencing project, and data
have been analyzed through several methods. How-
ever, bearing in mind the importance of biological
reasoning for conclusions about modes of evolution, it
seems wise not to dismiss the study by Seyfarth and
co-workers (81), since it is based on comparisons
between functional and non-functional MBL1 genes
in humans and other primates.
Concluding remarks
There seems to be a number of genes encoding
defense and/or immunity proteins which have evolved
rapidly since the divergence of humans and chimpan-
zees (86). However, Enard and co-workers have
recently shown (87) that positive selection acting
simultaneously on the same genes in humans and
other primates is not uncommon and not restricted
to a particular function, e.g. immune capacity. On the
other hand, independent selective sweeps in human,
chimpanzee, and orangutan were inferred for the
TLR6-1-10 gene cluster (87). Also, immune-related
genes are over-represented when recently occurring
selective events in human populations are considered.
The invention of farming—which led to a massive
increase of human population sizes, possibly facilitat-
ing the spread of certain infectious agents—and expo-
sure to new zoonoses following the domestication of
animals may have posed strong challenges on the
human immune system (86).
Recently, the TIR protein family has been pointed
out as an example where the existence of a limited
number of protein domains with relevant functions
has constrained evolution, resulting in the emergence
of proteins with identical architectures but lacking
orthologous relationship and performing different
functions in different lineages, the Drosophila Toll
proteins and the vertebrate TLRs being examples.
There are several examples of PRR domain architec-
tures which have emerged multiple times, suggesting
that parallel evolution may be a common phenome-
non in innate immunity evolution (28). Concerning
to what extent positive selection is acting on TLR
genes, evidence is somewhat contradictive. This
might, at least in part, be explained by differences
between species and by which SNPs are present in the
particular animal materials used to produce data sets.
However, the biological function of TLRs does not
exclude the possibility that they are parallel to the
MHC molecules as far as patterns of selection are
concerned. In general, the commonly accepted arms
race model of interaction between pathogens and
their hosts needs to be complemented by a concep-
tion of adaptive evolution as consisting of a series
of leaps, as it seems obvious—from a theoretical
point of view (59) and as a result of laboratory-
based research (72)—that adaptive evolution often
is episodic.
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